RELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS OF MOLSIDOMINE AND ITS METABOLITES IN HUMANS

被引：27

作者：

MEINERTZ, T

BRANDSTATTER, A

TRENK, D

JAHNCHEN, E

OSTROWSKI, J

GARTNER, W

机构：

[1] REHA ZENTRUM,BAD KROZINGEN,FED REP GER

[2] CASSELLA AG,MED RES LAB,FRANKFURT,FED REP GER

来源：

AMERICAN HEART JOURNAL | 1985年 / 109卷 / 03期

关键词：

D O I：

10.1016/0002-8703(85)90671-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：644 / 648

页数：5

共 11 条

[1]

BOHME E, 1982, MOLSIDOMIN NEUE ASPE, P37

[2] DETERMINATION OF MOLSIDOMINE IN PLASMA BY HIGH-PERFORMANCE LIQUID COLUMN CHROMATOGRAPHY [J].

DELL, D ;

CHAMBERLAIN, J .

JOURNAL OF CHROMATOGRAPHY, 1978, 146 (03) :465-472

[3]

FLECKENSTEINGRU.G, 1979, MOLSIDOMINE NEUE ASP, P56

[4]

HIRANO A, 1975, J NEUROPATH EXP NEUR, V34, P1, DOI 10.1097/00005072-197501000-00001

[5] KINETICS OF PHARMACOLOGIC RESPONSE [J].

HOLFORD, NHG ;

SHEINER, LB .

PHARMACOLOGY & THERAPEUTICS, 1982, 16 (02) :143-166

[6]

KOYAMA H, 1983, Journal of Takeda Research Laboratories, V42, P52

[7]

OSTROWSKI J, 1979, MOLSIDOMINE URBAN SC, P69

[8]

OSTROWSKI J, 1ST P EUR C BIOPH PH, V3, P418

[9]

ROWLAND M, 1980, CLIN PHARMACOKINET, P124

[10] BIOTRANSFORMATION OF MOLSIDOMINE (N-ETHOXYCARBONYL-3-MORPHOLINOSYDNONIMINE), A NEW ANTIANGINAL AGENT, IN RATS [J].

TANAYAMA, S ;

NAKAI, Y ;

FUJITA, T ;

SUZUOKI, Z ;

IMASHIRO, Y ;

MASUDA, K .

XENOBIOTICA, 1974, 4 (03) :175-191

← 1 2 →